BNP Paribas Asset Management
LKFT

BNP Paribas Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

BNP Paribas Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13,127
Closed -$676K – 1013
2015
Q2 		$676K Buy
+13,127
New +$696K 0.01% 899

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BNP Paribas Asset Management's LKFT Position: Q3 2015 in Review

BNP Paribas Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2015, closing a stake of 13,127 shares — an estimated $676K sold.

BNP Paribas Asset Management first reported a position in LKFT in Q2 2015 and held it in 1 quarter. The position peaked at $676K in Q2 2015. 38 funds tracked by Wall St. Rank hold LKFT as of Q3 2015.

  • BNP Paribas Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2015 after selling out during the quarter.
  • BNP Paribas Asset Management sold 13,127 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2015, an estimated $676K.
  • BNP Paribas Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 1 quarter.
  • BNP Paribas Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $676K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2015.

Based on BNP Paribas Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.